Magnitude of the Quality Assurance, Quality Control, and Testing in the Shiraz Cohort Heart Study.
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
04
2020
accepted:
15
07
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
23
4
2021
Statut:
epublish
Résumé
To determine the conclusive integrity in the Shiraz Cohort Heart Study (SCHS) project, management began quality assurance (QA) and quality control (QC) of the collected data throughout the study end-points. The QA is a focused process that prevents and detects data collection errors and verification of intended requirements in the SCHS. The QC is a subset of QA intended to capture errors in processing data through testing and preventive processes to identify problems, defects, or intended requirements. SCHS involved 10,000 males and females aged 40-70 over a 10-year follow-up period with cardiovascular diseases (CVDs) in the city of Shiraz, Iran. The study measured events and access to preventive care in Shiraz city. The SCHS identified unique barriers to select national study models in developing standardized measures related to variations in ethnicity, religion, cross-cultural considerations, and others. A suggested response to this problem was to develop a mechanism to standardize elements of the questionnaire, study design, and method of administration. This action was based on the geographically normal distribution of the Family Physician Health and Medical Services in Shiraz. Important QA and QC decisions were developed and adopted in the construction of the SCHS and follow-up to ensure conclusive integrity.
Identifiants
pubmed: 32851088
doi: 10.1155/2020/8179795
pmc: PMC7441427
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8179795Informations de copyright
Copyright © 2020 Nader Parsa et al.
Déclaration de conflit d'intérêts
There is no conflict of interests to declare.
Références
BMJ Open. 2015 Nov 09;5(11):e009200
pubmed: 26553836
CMAJ. 2012 Apr 3;184(6):657-61
pubmed: 22249987
Epidemiol Rev. 1998;20(1):71-80
pubmed: 9762510
Clin Trials. 2009 Apr;6(2):151-61
pubmed: 19342468
J Gerontol. 1992 Jul;47(4):S204-11
pubmed: 1624716
Ann Epidemiol. 2015 Jul;25(7):532-8.e1
pubmed: 25935712
Trials. 2017 Sep 7;18(1):418
pubmed: 28882167
BMJ Open. 2019 Apr 3;9(4):e026317
pubmed: 30948600
J Glaucoma. 2007 Dec;16(8):665-9
pubmed: 18091452
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Blood Press. 2016 Jun;25(3):162-8
pubmed: 26581308
Epidemiology. 2008 Jul;19(4):621-7
pubmed: 18496467
BMC Public Health. 2016 Aug 25;16(1):877
pubmed: 27557750
Genet Epidemiol. 2010 Sep;34(6):591-602
pubmed: 20718045
Anal Bioanal Chem. 2019 Jan;411(1):5-6
pubmed: 30415404
Biomed Res Int. 2018 Jun 13;2018:7656197
pubmed: 30009174